A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis

BACKGROUND: Pathologists are often faced with the dilemma of whether to recommend continuation of methotrexate therapy for psoriasis within the context of an existing pro-fibrogenic risk factor, in this instance, patients with genetic hemochromatosis. CASE PRESENTATIONS: We describe our experience w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathew, Joseph, Leong, May Y, Morley, Nick, Burt, Alastair D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1318467/
https://www.ncbi.nlm.nih.gov/pubmed/16316460
http://dx.doi.org/10.1186/1471-5945-5-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1318467/
https://www.ncbi.nlm.nih.gov/pubmed/16316460
http://dx.doi.org/10.1186/1471-5945-5-12

Ejemplares similares